{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:19:41Z","timestamp":1787242781184,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ELITechGroup S.p.A."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jcv.2019.104211","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T20:41:29Z","timestamp":1573245689000},"page":"104211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["CMV infection management in transplant patients in Italy"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-5061","authenticated-orcid":false,"given":"Paolo Antonio","family":"Grossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Baldanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Andreoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Federico","family":"Perno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jcv.2019.104211_bib0005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/TP.0b013e318235c7fc","article-title":"Summary of the british transplantation society guidelines for the prevention and management of CMV disease after solid organ transplantation","volume":"92","author":"Andrews","year":"2011","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.jcv.2019.104211_bib0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics"},{"issue":"4","key":"10.1016\/j.jcv.2019.104211_bib0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/QCO.0000000000000173","article-title":"Clinical utility of cytomegalovirus viral load in solid organ transplant recipients","volume":"28","author":"Dioverti","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"Dec 6","key":"10.1016\/j.jcv.2019.104211_bib0020","volume":"19","author":"Navarro","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.104211_bib0025","first-page":"1","article-title":"Collaborative study to evaluate the proposed 1st WHO international standard for human cytomegalovirus for nucleic acid amplification-based assays","author":"Freyer","year":"2010","journal-title":"WHO\/BS\/10.2138"},{"issue":"4","key":"10.1016\/j.jcv.2019.104211_bib0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.biologicals.2016.04.005","article-title":"Minor PD on behalf of the Collaborative Study Group. A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology","volume":"44","author":"Fryer","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.jcv.2019.104211_bib0035","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000002191","article-title":"On behalf of the transplantation society international CMV consensus group. The third international consensus guidelines on the management of cytomegalovirus in solid organ transplantation","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jcv.2019.104211_bib0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bjh.12363","article-title":"On behalf of the British Committee for Standards in Haematology; British Society of Blood and Marrow Transplantation; UK Virology Network. Management of cytomegalovirus infection in haemopoietic stem cell transplantation","volume":"162","author":"Emery","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jcv.2019.104211_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)","author":"Ljungman","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"Suppl 37","key":"10.1016\/j.jcv.2019.104211_bib0050","first-page":"S165","article-title":"On behalf of the Societ\u00e0 Italiana di Nefrologia. [Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology]","volume":"24","author":"Cornella","year":"2007","journal-title":"G. Ital. Nefrol."},{"issue":"July","key":"10.1016\/j.jcv.2019.104211_bib0055","article-title":"Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: a multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies","volume":"16","author":"Girmenia","year":"2019","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.jcv.2019.104211_bib0060","unstructured":"Data from Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO). Available at http:\/\/www.gitmo.it. Last Accessed 12 August 2019. [In Italian]."},{"key":"10.1016\/j.jcv.2019.104211_bib0065","unstructured":"Trapianto di midollo osseo e di cellule staminali emopoietiche: l\u2019impegno di Gitmo. Intervista alla presidente Francesca Bonifazi_ https:\/\/www.quotidianosanita.it\/scienza-e-farmaci\/articolo.php?articolo_id=73518. Last Accessed 12 August 2019. [In Italian]."},{"key":"10.1016\/j.jcv.2019.104211_bib0070","unstructured":"Data from 2018 annual report of the National Transplant Centre of the Italian National Institute of Health (ISS). Available at http:\/\/www.trapianti.salute.gov.it\/imgs\/C_17_cntPubblicazioni_266_allegato.pdf. Last Accessed 12 August 2019. [In Italian]."},{"key":"10.1016\/j.jcv.2019.104211_bib0075","unstructured":"Fondazione Censis. IL VALORE DEL TRAPIANTO. Un\u2019analisi empirica dei consumi sanitari e dei costi dei trapiantati di rene in Italia 13192_2011 sintesi [In Italian]."},{"key":"10.1016\/j.jcv.2019.104211_bib0080","unstructured":"Data from Italian Ministry of Health. Valutazione di qualit\u00e0 dell\u2019attivit\u00e0 del trapianto di Fegato 2000-2016. Available at https:\/\/trapianti.sanita.it\/statistiche\/attivita\/2019_D_QUALITA_ORGANI_FEGATO_00-16.pdf. Last Accessed 2 August 2019. [In Italian]."},{"key":"10.1016\/j.jcv.2019.104211_bib0085","unstructured":"Data from Italian Ministry of Health. Valutazione di qualit\u00e0 dell\u2019attivit\u00e0 del trapianto di Rene 2000-2015. Available at https:\/\/trapianti.sanita.it\/statistiche\/attivita\/2017_D_QUALITA_ORGANI_RENE_00-15.pdf. Last Accessed 2 August 2019. [In Italian]."},{"key":"10.1016\/j.jcv.2019.104211_bib0090","unstructured":"Data from Italian Ministry of Health. Valutazione di qualit\u00e0 dell\u2019attivit\u00e0 del trapianto di Cuore 2000-2014. Available at https:\/\/trapianti.sanita.it\/statistiche\/attivita\/2017_D_QUALITA_ORGANI_CUORE_00-15.pdf. Last Accessed 2 August 2019. [In Italian]."},{"issue":"9","key":"10.1016\/j.jcv.2019.104211_bib0095","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2217\/imt-2015-0028","article-title":"Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients","volume":"8","author":"Lilleri","year":"2016","journal-title":"Immunotherapy"},{"issue":"Jul 1","key":"10.1016\/j.jcv.2019.104211_bib0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/TP.0b013e31817889e4","article-title":"Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation","volume":"86","author":"Gerna","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2019.104211_bib0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-018-0141-5","article-title":"Protective environment for hematopoietic cell transplant (HSCT) recipients: the Infectious Diseases working Party EBMT analysis of global recommendations on health-care facilities","author":"Styczynski","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jcv.2019.104211_bib0110","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/TP.0000000000000160","article-title":"Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment","volume":"98","author":"Stern","year":"2014","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.jcv.2019.104211_bib0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"on behalf of the Transplantation Society International CMV Consensus Group. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"issue":"19 Suppl 5","key":"10.1016\/j.jcv.2019.104211_bib0120","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2146\/ajhp060377","article-title":"Etiology and impact of cytomegalovirus disease on solid organ transplant recipients","volume":"63","author":"McDevitt","year":"2006","journal-title":"Am. J. Health. Syst. Pharm."},{"issue":"1","key":"10.1016\/j.jcv.2019.104211_bib0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"3","key":"10.1016\/j.jcv.2019.104211_bib0130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","article-title":"Cytomegalovirus infections in solid organ transplantation: a review","volume":"45","author":"Ramanan","year":"2013","journal-title":"Infect. Chemother."},{"key":"10.1016\/j.jcv.2019.104211_bib0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2055-6640(20)30457-X","article-title":"Human cytomegalovirus and transplantation: drug development and regulatory issues","volume":"2","author":"McIntosh","year":"2016","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.jcv.2019.104211_bib0140","series-title":"Anwendung Und Dosierung Von CMV-Immunglobulinen Nach Transplantation. 16 October","author":"Sankawa","year":"2014"},{"issue":"2","key":"10.1016\/j.jcv.2019.104211_bib0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/13543784.2017.1274733","article-title":"Letermovir for the management of cytomegalovirus infection","volume":"26","author":"Bowman","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jcv.2019.104211_bib0150","first-page":"371","article-title":"On behalf of the North Italy Transplant Program. Kidney transplantation in the north Italy transplant program","author":"Cardillo","year":"2000","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.jcv.2019.104211_bib0155","article-title":"Cytomegalovirus in solid organ transplant recipients -Guideline of the American Society of Transplantation Infectious Disease Community of Practice","volume":"28","author":"Razonable","year":"2019","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.jcv.2019.104211_bib0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hemonc.2017.05.001","article-title":"Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation","volume":"10","author":"Camargo","year":"2017","journal-title":"Hematol. Stem Cell Ther."},{"issue":"9","key":"10.1016\/j.jcv.2019.104211_bib0165","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-016-2711-1","volume":"95","author":"Ullmann","year":"2016","journal-title":"Ann. Hematol."},{"issue":"Suppl. 7","key":"10.1016\/j.jcv.2019.104211_bib0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12594","article-title":"Cytomegalovirus infection in solid organ transplant recipients","volume":"20","author":"Lumbreras","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2019.104211_bib0175","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/375075","article-title":"CMV serostatus of donor-recipient pairs influences the risk of CMV infection\/reactivation in HSCT patients","author":"Jaskula","year":"2012","journal-title":"Bone Marrow Res."},{"issue":"23","key":"10.1016\/j.jcv.2019.104211_bib0180","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","article-title":"How we treat cytomegalovirus in hematopoietic cell transplant recipients","volume":"113","author":"Boeckh","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jcv.2019.104211_bib0185","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"For the French CMV Resistance Survey Study Group. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.jcv.2019.104211_bib0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cid\/cix259","article-title":"Risk factors and outcomes of ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients","volume":"65","author":"Fisher","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jcv.2019.104211_bib0195","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/tid.12537","article-title":"Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study","volume":"18","author":"Young","year":"2016","journal-title":"Transpl. Infect. Dis."},{"issue":"Mar 3","key":"10.1016\/j.jcv.2019.104211_bib0200","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jac\/dkn521","article-title":"Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus","volume":"63","author":"Allice","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.jcv.2019.104211_bib0205","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/jit475","article-title":"High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation","volume":"209","author":"Shmueli","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.jcv.2019.104211_bib0210","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer letermovir resistance","volume":"59","author":"Chou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Oct 10","key":"10.1016\/j.jcv.2019.104211_bib0215","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/phar.1987","article-title":"Ganciclovir-resistant cytomegalovirus infection in abdominal solid OrganTransplant recipients: case series and review of the literature","volume":"37","author":"Rolling","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jcv.2019.104211_bib0220","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fmicb.2016.01317","article-title":"Detection of low frequency multi-drug resistance and novel putative maribavir resistance in immunocompromised pediatric patients with cytomegalovirus","volume":"7","author":"Houldcroft","year":"2016","journal-title":"Front. Microbiol."},{"issue":"23","key":"10.1016\/j.jcv.2019.104211_bib0225","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2016-06-688432","article-title":"How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients","volume":"128","author":"El Chaer","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2019.104211_bib0230","unstructured":"RAVN 2017. Usage of antivirals and the Occurrence of Antiviral Resistance in Norway. Norwegian Institute of Public Health, Oslo 2018. ISBN: 978-82-8082-973-3."},{"issue":"May 5","key":"10.1016\/j.jcv.2019.104211_bib0235","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.humimm.2004.02.007","article-title":"Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs","volume":"65","author":"Baldanti","year":"2004","journal-title":"Hum. Immunol."},{"issue":"May 10","key":"10.1016\/j.jcv.2019.104211_bib0240","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1705986","article-title":"Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients","volume":"41","author":"Gerna","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.jcv.2019.104211_bib0245","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/TP.0000000000001531","article-title":"Effectiveness of preemptive therapy for cytomegalovirus disease in pediatric liver transplantation","volume":"101","author":"Nicastro","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jcv.2019.104211_bib0250","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/135965350701200108","article-title":"Bergamo Transplant Group. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study","volume":"12","author":"Gerna","year":"2007","journal-title":"Antivir. Ther."},{"issue":"8","key":"10.1016\/j.jcv.2019.104211_bib0255","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.bbmt.2018.03.005","article-title":"AMCLI-GLaIT working group. Cytomegalovirus and epstein-barr virus DNA kinetics in whole blood and plasma of allogeneic hematopoietic stem cell transplantation recipients","volume":"24","author":"Lazzarotto","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"Dec 4","key":"10.1016\/j.jcv.2019.104211_bib0260","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0924-8579(00)00279-X","article-title":"Use of CMV transcripts for monitoring of CMV infections in transplant recipients","volume":"16","author":"Gerna","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"5","key":"10.1016\/j.jcv.2019.104211_bib0265","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2174\/187152611797636703","article-title":"Overview of the diagnosis of cytomegalovirus infection","volume":"11","author":"Ross","year":"2011","journal-title":"Infect. Disord. Drug Targets"},{"issue":"5","key":"10.1016\/j.jcv.2019.104211_bib0270","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1128\/JCM.38.5.1845-1853.2000","article-title":"Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients","volume":"38","author":"Gerna","year":"2000","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.jcv.2019.104211_bib0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11908-996-0034-4","article-title":"Recent advances in the management of infections in liver transplant recipients","volume":"3","author":"Singh","year":"2001","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"2","key":"10.1016\/j.jcv.2019.104211_bib0280","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz003","article-title":"Correlation of cytomegalovirus (CMV) disease severity and mortality with CMV viral burden in CMV-Seropositive donor and CMV-Seronegative solid organ transplant recipients","volume":"6","author":"McBride","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.jcv.2019.104211_bib0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcv.2015.06.006","article-title":"Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients","volume":"69","author":"Tan","year":"2015","journal-title":"J. Clin. Virol."},{"issue":"11","key":"10.1016\/j.jcv.2019.104211_bib0290","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.bbmt.2011.08.014","article-title":"Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies","volume":"17","author":"Mu\u00f1oz-Cobo","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.jcv.2019.104211_bib0295","doi-asserted-by":"crossref","unstructured":"Griffiths PD, Rothwell E, Raza M, et al. Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy. PLoS ONE. 2016; 11(9): e0163722. 10.1371\/journal.pone.0163722.","DOI":"10.1371\/journal.pone.0163722"},{"issue":"9","key":"10.1016\/j.jcv.2019.104211_bib0300","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","article-title":"Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy","volume":"12","author":"Atabani","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.jcv.2019.104211_bib0305","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bmt.1703604","article-title":"Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation","volume":"30","author":"Hebart","year":"2002","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.jcv.2019.104211_bib0310","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jcv.2012.08.017","article-title":"Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay","volume":"55","author":"Furione","year":"2012","journal-title":"J. Clin. Virol."},{"issue":"12","key":"10.1016\/j.jcv.2019.104211_bib0315","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/cid\/cis212","article-title":"Interpreting Quantitative Cytomegalovirus DNA Testing: Understanding the Laboratory Perspective","volume":"54","author":"Kraft","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1016\/j.jcv.2019.104211_bib0320","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/cis900","article-title":"An international multicenter performance analysis of cytomegalovirus load tests","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jcv.2019.104211_bib0325","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/JCM.03292-15","article-title":"Commutability of cytomegalovirus WHO international standard in different matrices","volume":"54","author":"Jones","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2019.104211_bib0330","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/cid\/cit096","article-title":"Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the world health organization international standard is predictive of CMV disease resolution in transplant recipients","volume":"56","author":"Razonable","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.104211_bib0335","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jcv.2016.07.001","article-title":"On behalf of the AMCLI \u2212 Infections in Transplant Working Group GLaIT. Nation-wide measure of variability in HCMV, EBV and BKV DNA quantification among centers involved in monitoring transplanted patients","volume":"82","author":"Abbate","year":"2016","journal-title":"J. Clin. Virol."},{"issue":"12","key":"10.1016\/j.jcv.2019.104211_bib0340","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/ctr.12473","article-title":"Multicenter comparison of laboratory performance in Cytomegalovirus and Epstein-Barr virus viral load testing using international standards","volume":"28","author":"Rychert","year":"2014","journal-title":"Clin. Transplant."},{"issue":"Feb 2","key":"10.1016\/j.jcv.2019.104211_bib0345","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/JCM.02044-16","article-title":"Progress in quantitative viral load testing: variability and impact of the WHO quantitative international standards","volume":"55","author":"Hayden","year":"2017","journal-title":"J. Clin. Microbiol."},{"issue":"2 Suppl","key":"10.1016\/j.jcv.2019.104211_bib0350","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.bbmt.2014.12.034","article-title":"Reprint of: recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies","volume":"21","author":"Boeckh","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.jcv.2019.104211_bib0355","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbmt.2017.11.038","article-title":"Impact of cytomegalovirus viral load on probability of spontaneous clearance and response to preemptive therapy in allogeneic stem cell transplantation recipients","volume":"24","author":"Camargo","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"10","key":"10.1016\/j.jcv.2019.104211_bib0360","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1128\/JCM.01495-15","article-title":"Commutability of the first world health organization international standard for human cytomegalovirus","volume":"53","author":"Hayden","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2019.104211_bib0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2019.05.012","article-title":"Collaborative national multicenter for the identification of conversion factors from copies\/mL to international units\/mL for the normalization of HCMV DNA load","author":"Sidoti","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"10","key":"10.1016\/j.jcv.2019.104211_bib0370","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e3181d54ba6","article-title":"Can preemptive cytomegalovirus monitoring be as effective as universal prophylaxis when implemented as the standard of care in patients at moderate risk?","volume":"89","author":"McGillicuddy","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jcv.2019.104211_bib0375","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/tid.12023","article-title":"Cost analysis in favor of a combined approach for cytomegalovirus after kidney transplantation: a single-center experience","volume":"15","author":"Hellemans","year":"2013","journal-title":"Transpl. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jcv.2019.104211_bib0380","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1524-4733.2002.54117.x","article-title":"Modeling costs and cost-effectiveness of different CMV management strategies in liver transplant recipients as a support for current and future decision making","volume":"5","author":"Annemans","year":"2002","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jcv.2019.104211_bib0385","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/QCO.0000000000000170","article-title":"Approach to drug-resistant cytomegalovirus in transplant recipients","volume":"28","author":"Chou","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jcv.2019.104211_bib0390","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01596-09","article-title":"In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246","volume":"54","author":"Lischka","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2019.104211_bib0395","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2019.104211_bib0400","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation","volume":"370","author":"Chemalay","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jcv.2019.104211_bib0405","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/tri.12225","article-title":"Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study","volume":"27","author":"Stoelben","year":"2014","journal-title":"Transpl. Int."},{"issue":"Feb 1-2","key":"10.1016\/j.jcv.2019.104211_bib0410","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1386-6532(01)00227-X","article-title":"Multiplex real-time NASBAfor monitoring expression dynamics of human cytomegalovirus encoded IE1 and pp67 RNA","volume":"24","author":"Greijer","year":"2002","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2019.104211_bib0415","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcv.2015.07.299","article-title":"Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications","volume":"70","author":"Calarota","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2019.104211_bib0420","first-page":"329","article-title":"Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients","volume":"38","author":"Ritt\u00e0","year":"2015","journal-title":"New Microbiol."},{"key":"10.1016\/j.jcv.2019.104211_bib0425","article-title":"A bi-centric longitudinal analysis of HCMV-specific T-cell immune response in kidney tranplsant recipients (KTRs)- abstract","author":"Cassaniti","year":"2017","journal-title":"European Symposium of Clinical Virology ESCV"},{"issue":"7","key":"10.1016\/j.jcv.2019.104211_bib0430","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2003-05-1433","article-title":"Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy","volume":"105","author":"Trivedi","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jcv.2019.104211_bib0435","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.bbmt.2015.05.015","article-title":"Immunotherapy with donor t cells sensitized with overlapping pentadecapeptides for treatment of persistent cytomegalovirus infection or viremia","volume":"21","author":"Khoene","year":"2015","journal-title":"Biol. Blood Marrow Transplant."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219302410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219302410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:11:49Z","timestamp":1761361909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653219302410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":87,"alternative-id":["S1386653219302410"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2019.104211","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CMV infection management in transplant patients in Italy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2019.104211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104211"}}